Monarch Partners Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.16M | Buy |
|
|||||
|
2022
Q3 | $2.86M | Buy |
|
|||||
|
2022
Q2 | $2.75M | Buy |
|
|||||
|
2022
Q1 | $1.63M | Hold |
|
|||||
|
2021
Q4 | $1.5M | Buy |
|
|||||
|
2021
Q3 | $1.45M | Buy |
|
|||||
|
2021
Q2 | $1.56M | Buy |
|
|||||
|
2021
Q1 | $974K | Sell |
|
|||||
|
2020
Q4 | $848K | Sell |
|
|||||
|
2020
Q3 | $1.42M | Buy |
|
|||||
|
2020
Q2 | $808K | Buy |
|
|||||
|
2020
Q1 | $448K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $511K | Hold |
|
|||||
|
2018
Q4 | $580K | Buy |
|
|||||
|
2018
Q3 | $418K | Buy |
|
|||||
|
2018
Q2 | $533K | Hold |
|
|||||
|
2018
Q1 | $571K | Buy |
|
|||||
|
2017
Q4 | $264K | Buy |
|